Boehringer Ingelheim ties up with Indian firm to reach Tier 2 cities

Boehringer Ingelheim India has entered into a strategic partnership with Vvaan Lifesciences Pvt Ltd to distribute its pet parasiticide portfolio in Tier 2 cities of the country. The collaboration, an initiative under Boehringer Ingelheim India’s animal health accelerated growth plan, marks a significant step in expanding the company’s reach and enhancing customer value in the animal health sector. India’s pet health market is currently worth around €115 million ($129 million, or Rs1,078 crore). According to...

German pharma company introduces broad-spectrum tablet for parasite control in pet dogs

Boehringer Ingelheim, a German family-owned research-driven biopharmaceutical company and global leader in animal health, has announced the launch of NexGard SPECTRA® chewable tablets in India following its approval by the Central Drugs Standard Control Organisation. After the launch of NexGard X and L in 2020 and NexGard S and M (afoxolaner) in 2023, this represents an expansion of the NexGard product line for dogs aged at least two months and weighing 2 kg or more....